LAB EBITDA Growth
Standard Biotools Inc · EBITDA Growth
LAB EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-13.81%period ending
LAB TTM EBITDA YoY % (-18.41% → -13.81%)
Year-over-year change
High-resolution chart · PNG
LAB ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| -13.806% | |
| 5.6494% | |
| 5.6608% | |
| -13.5745% | |
| -9.4758% | |
| -31.3839% | |
| -79.4741% | |
| -54.9778% | |
| -15.6781% | |
| 42.009% | |
| 70.1602% | |
| 67.5705% | |
| 56.1717% | |
| -12.994% | |
| -292.1068% | |
| -218.6463% | |
| -255.743% | |
| -173.4522% | |
| -35.1964% | |
| -80.2094% | |
| -11.7521% | |
| 7.224% | |
| 29.7698% | |
| 37.7247% | |
| 19.991% | |
| 11.6512% | |
| -37.7771% | |
| -43.821% | |
| -46.335% | |
| -30.4655% | |
| 14.0404% | |
| 34.838% | |
| 38.9595% | |
| 36.8273% | |
| 30.2311% | |
| 8.1642% | |
| -11.6258% | |
| -27.2825% | |
| -34.6941% | |
| -29.5396% | |
| -2.7624% | |
| 9.0859% | |
| 15.4833% | |
| 7.1347% | |
| -29.649% | |
| -74.2121% | |
| -272.3742% | |
| -244.9314% | |
| -170.9782% | |
| -99.4822% | |
| 19.5916% | |
| 21.8012% | |
| 22.3959% | |
| 28.7671% | |
| 7.5561% | |
| 5.6404% | |
| -3.4897% | |
| -38.5098% | |
| -32.5781% | |
| -18.4054% |